Sj. Ritter et al., N-(4-HYDROXYPHENYL)RETINAMIDE (FENRETINIDE) AND NEPHRECTOMY ALTER NORMAL PLASMA RETINOL-BINDING PROTEIN-METABOLISM, Journal of nutritional biochemistry, 6(12), 1995, pp. 689-696
We have reported previously that injecting vitamin A-deficient rats wi
th N-(4-hydroxyphenyl)retinamide causes a significant reduction in the
liver retinol-binding protein concentration and a 2 fold rise in the
kidney retinol-binding protein concentration. This presumably reflects
a rapid translocation of retinol-binding protein from the liver to th
e kidney through the plasma, although no rise in plasma retinol-bindin
g protein is detected. In the present studies, nephrectomized rats wer
e used to determine if retinol-binding protein accumulating in kidneys
passes through the plasma. Bilateral nephrectomy in control rats caus
ed the plasma retinol-binding protein concentration to approximately d
ouble by 5 hr postsurgery. However, nephrectomy plus N-(4-hydroxypheny
l)retinamide treatment did not result in an increase in the plasma ret
inol-binding protein concentration. Therefore, the lowering of liver r
etinol-binding protein concentration in response to N-(4-hydroxyphenyl
)retinamide treatment was not accounted for by an accumulation of reti
nol-binding protein in the plasma compartment. Interestingly, the musc
le retinol-binding protein concentration increased with nephrectomy pl
us N-(4-hydroxyphenyl)retinamide treatment. The ratio of muscle retino
l-binding protein plasma retinol-binding protein in vitamin A-deficien
t nephrectomized rats treated with N-(4-hydroxyphenyl)retinamide was s
ignificantly higher than in comparable rats treated with either carrie
r or retinol. We conclude that in vivo N-(4-hydroxyphenyl)retinamide i
nduces the secretion of retinol-binding protein from the liver. Since
the N-(4-hydroxyphenyl)retinamide-retinol-binding protein complex does
not bind with transthyretin it rapidly leaves the plasma. In non-neph
rectomized rats this complex is rapidly filtered by the kidney. Nephre
ctomizing rats causes the retinol-binding protein secreted in response
to N-(4-hydroxyphenyl)retinamide to diffuse into interstitial fluid